PGP9.5 overexpression in esophageal squamous cell carcinoma
- PMID: 14571718
PGP9.5 overexpression in esophageal squamous cell carcinoma
Abstract
Background/aims: PGP9.5 is a ubiquitin hydrolase widely expressed in neuronal tissue at all stages of neuronal differentiation and has been used as a neuroendocrine marker. Recently, it has been proved that PGP9.5 expression was highly observed in squamous cell carcinoma of lung cancer, suggesting that it might be a tumor marker for squamous cell carcinoma. To better characterize its role in digestive tract cancers, we examined PGP9.5 expression retrospectively in esophageal cancers.
Methodology: We examined PGP9.5 expression retrospectively in 40 resected esophageal cancers (squamous cell carcinoma) and 10 gastric cancers (adenocarcinoma) using immunohistochemistry.
Results: Of 40 esophageal cancer specimens, 19 (48%) exhibited positive staining with PGP9.5 in most tumor cells, while no PGP9.5 expression was observed in any of the 10 gastric cancers.
Conclusions: Although the precise mechanism underlying the effect of PGP9.5 on oncogenicity remains to be proven, it was confirmed that it may be a potential marker for esophageal squamous cell carcinoma.
Similar articles
-
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma.Anticancer Res. 2004 Nov-Dec;24(6):3731-4. Anticancer Res. 2004. PMID: 15736404
-
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer.Am J Pathol. 1999 Sep;155(3):711-5. doi: 10.1016/S0002-9440(10)65169-3. Am J Pathol. 1999. PMID: 10487828 Free PMC article.
-
PGP9.5 as a marker for invasive colorectal cancer.Clin Cancer Res. 2002 Jan;8(1):192-5. Clin Cancer Res. 2002. PMID: 11801558
-
Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.Hum Pathol. 2001 Nov;32(11):1157-65. doi: 10.1053/hupa.2001.28951. Hum Pathol. 2001. PMID: 11727253
-
Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.Hum Pathol. 2010 Oct;41(10):1456-65. doi: 10.1016/j.humpath.2010.04.003. Hum Pathol. 2010. PMID: 20621329
Cited by
-
Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.Med Oncol. 2013 Mar;30(1):418. doi: 10.1007/s12032-012-0418-2. Epub 2013 Jan 13. Med Oncol. 2013. PMID: 23315218
-
Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.J Biol Chem. 2013 May 3;288(18):12615-26. doi: 10.1074/jbc.M112.435701. Epub 2013 Mar 29. J Biol Chem. 2013. PMID: 23543736 Free PMC article.
-
Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis.Virchows Arch. 2022 Mar;480(3):577-585. doi: 10.1007/s00428-021-03199-y. Epub 2021 Nov 10. Virchows Arch. 2022. PMID: 34757486
-
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.Cancer Sci. 2006 Jun;97(6):523-9. doi: 10.1111/j.1349-7006.2006.00202.x. Cancer Sci. 2006. PMID: 16734731 Free PMC article.
-
[Effect of liposomal transfection of UCH-L1 siRNA on proliferation and apoptosis of lung cancer cell line H157].Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):292-6. doi: 10.3779/j.issn.1009-3419.2010.04.04. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20677552 Free PMC article. Chinese.
MeSH terms
Substances
LinkOut - more resources
Medical